The XCL1/XCR1 axis is upregulated in type 1 diabetes and aggravates its pathogenesis
Authors:
- Camilla TondelloCTCamilla Tondello
- Christine BenderCBChristine Bender
- Gregory J. GoldenGGGregory J. Golden
- Deborah PuppeDPDeborah Puppe
- Elisa BlickberndtEBElisa Blickberndt
- Monika BayerMBMonika Bayer
- Giulia K. BuchmannGBGiulia K. Buchmann
- Josef PfeilschifterJPJosef Pfeilschifter
- Malte BachmannMBMalte Bachmann
- Edith HintermannEHEdith Hintermann
- Ralf P. BrandesRBRalf P. Brandes
- Michael R. BettsMBMichael R. Betts
Open Access
- 27 February 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (7)
Abstract
Type 1 diabetes (T1D) is precipitated by the autoimmune destruction of the insulin-producing β cells in the pancreatic islets of Langerhans. Chemokines have been identified as major conductors of islet infiltration by autoaggressive leukocytes, including antigen-presenting cells and islet autoantigen–specific T cells. We have previously generated a road map of gene expression in the islet microenvironment during T1D in a mouse model and found that most of the chemokine axes are chronically upregulated during T1D. The XCL1/XCR1 chemokine axis is of particular interest, since XCR1 is exclusively expressed on conventional DCs type 1 (cDC1) that excel by their high capacity for T cell activation. Here, we demonstrate that cDC1-expressing XCR1 are present in and around the islets of patients with T1D and of individuals with islet autoantibody positivity. Furthermore, we show that XCL1 plays an important role in the attraction of highly potent DCs expressing XCR1 to the islets in an inducible mouse model for T1D. XCL1-deficient mice display a diminished infiltration of XCR1 + cDC1 and, subsequently, a reduced magnitude and activity of islet autoantigen–specific T cells, resulting in a profound decrease in T1D incidence. Interference with the XCL1/XCR1 chemokine axis might constitute a novel therapy for T1D.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (CH-806/2-1)
- Landesoffensive zur Entwicklung wissenschaftlich‐ökonomischer Exzellenz’ (LOEWE), Center ‘Translationale Medizin und Pharmakologie’ (TMP-IF-01)
- Deutsche Forschungsgemeinschaft (SFB1531)
- Deutsche Forschungsgemeinschaft (#456687919)
- Excellence Cluster Cardiopulmonary Institute (EXC2026)
- Excellence Cluster Cardiopulmonary Institute (#390649896)
- United States National Institutes of Health (UC4 DK112217)
- JDRF Postdoctoral Fellowship grant JDRF PDF (3-PDF-2023-1323-A-N)
This publication has 44 references indexed in Scilit:
- CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetesJournal of Autoimmunity, 2009
- Comparative analysis of transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel immune response players in T-Cell activationBMC Genomics, 2008
- Islet-Specific Expression of CXCL10 Causes Spontaneous Islet Infiltration and Accelerates Diabetes DevelopmentThe Journal of Immunology, 2005
- Among CXCR3 Chemokines, IFN-γ-Inducible Protein of 10 kDa (CXC Chemokine Ligand (CXCL) 10) but Not Monokine Induced by IFN-γ (CXCL9) Imprints a Pattern for the Subsequent Development of Autoimmune DiseaseThe Journal of Immunology, 2003
- β cells are responsible for CXCR3-mediated T-cell infiltration in insulitisNature Medicine, 2002
- Islet-Specific Th1, But Not Th2, Cells Secrete Multiple Chemokines and Promote Rapid Induction of Autoimmune DiabetesThe Journal of Immunology, 1999
- Identification of Single C Motif-1/Lymphotactin Receptor XCR1Journal of Biological Chemistry, 1998
- How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic modelImmunity, 1994
- Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well platesJournal of Virological Methods, 1991
- Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: Role of anti-self (virus) immune responseCell, 1991